Not sure why it’s so hard for Hall of Fame voters to get on board with the ideas that (a) it’s not fair to assume someone was on steroids when there is no evidence of it; and (b) Jeff Bagwell, on the merits, posted a Hall of Fame career. But considering it’s highly unlikely he’ll be inducted this year, a healthy number of voters have a hard time with those concepts.
Thank goodness for Ken Rosenthal, then. I don’t agree with everything he says in his Hall of Fame column — what fun would that be? — but how anyone can disagree with this is beyond me.
When voting, one should only consider the facts at hand. If Bagwell is later revealed to have been a user, maybe I will stop voting for him, if he isn’t already in the Hall. There is little doubt that he is deserving otherwise, unless you’re somehow unimpressed by his .408 on-base percentage and .540 slugging mark, not to mention his baserunning, defense at first base and leadership of the Astros during his 15-year career … For now, all I know is one thing: I’m not withholding votes based on hearsay and innuendo.
Ken Rosenthal of The Athletic reports that the Orioles and Mets have discussed a trade for Matt Harvey.
Rosenthal says the discussions have involved a reliever going back to New York and observes that that Harvey and Brad Brach are projected for similar salaries in their final arbitration years which could make a financial match.
There have been a handful of Harvey rumors over the past couple of days, with a report coming out yesterday that the Mets have spoken with at least two teams about their fallen ace. Jon Heyman said today that the Rangers may have been one of those teams. Maybe the Orioles are the second or, perhaps, the third?
All if this has to be pretty deflating if you’re a Mets fan, given the promise and dominance Harvey showed before injuries waylaid him the past two seasons. Harvey is still just 28 but he made only 18 starts and one relief appearance last year, posting a 6.70 ERA with a 67/47 K/BB ratio in 92.2 innings.
If the Mets can’t find a trade partner this winter, they’ll clearly hope for him to rebound at least a little bit in 2018, allowing him to regain some trade value.